The competitive landscape for pharmaceutical and life sciences companies around the world is changing rapidly. We are now in the “New Health Economy” in which drug pricing pressures, scientific breakthroughs, expanding global demand for health care access, and emerging digital and analytical capabilities are pushing the health care industry toward a new ecosystem defined by collaboration, quality and consumer value.
Change requires a new strategic approach – one that enables companies to understand market trends, and build the internal capabilities needed to execute. This article explores specific trends affecting pharmaceutical and life sciences companies and provides clear guidance for how organizations can best respond.
Strategy& Pharmaceutical and life sciences Leader
Tel: +1 (703) 682 5755
UK Pharmaceuticals and life sciences Consulting Leader, PwC’s Strategy&
Tel: +44 (0)20 7804 3744